Advancing Healthcare Through Pioneering Research Solutions
Propelling Healthcare Forward with Cutting-Edge Biostatistics solutions for Oncology
Innovating Healthcare through Pioneering Research Solutions in Pre-Clinical Immuno-Oncology Data Analytics
Transforming healthcare through the precision of Multi-Omics analysis in immuno-oncology data analytics
At Aomics, we are spearheading a revolution in healthcare through cutting-edge immuno-oncology research. Our unwavering dedication to pioneering comprehensive research solutions has propelled us to the forefront of this transformative field. Armed with a deep reservoir of expertise encompassing biostatistics consultation, statistical programming, clinical data management, and regulatory compliance, we are uniquely equipped to facilitate groundbreaking discoveries that will reshape the future of medicine.
Elevating healthcare through innovation, Aomics pioneers comprehensive research solutions. With expertise spanning biostatistics consultation, statistical programming, clinical data management, and regulatory compliance, we drive impactful discoveries that shape the future of medicine.
Explore our Solutions
Statistical programming for clinical services refers to the use of computer programming languages, such as SAS (Statistical Analysis System), R, and Python, to perform statistical analyses on clinical trial data.
Assess effectiveness of Immuno-therapy
Our proprietary AI-driven algorithms for immunotherapy are developed by using latest scientific research to analyze large amounts of multi-omics healthcare/clinical data. At the forefront of innovation, our pioneering AI-driven algorithms for immunotherapy leverage the latest scientific research to dissect vast multi-omics healthcare and clinical data. Through meticulous analysis, these proprietary algorithms unveil novel immune biomarkers, paving the path for a new era in cancer treatment.
Clinical Data Management
Our services span the entire data lifecycle, from collection and validation to analysis and reporting. With rigorous attention to detail, we ensure data integrity, compliance, and accuracy throughout your trials.
Artificial intelligence & Machine Learning for Immuno-informatics
We develop powerful and innovative AI models and pipelines for Immuno-informatics. By leveraging AI, we assist making powerful insights from the high-throughput immunological data. Merging Artificial Intelligence and Machine Learning. Delve into the synergy of cutting-edge technology and immunology, as AI and ML decode complex immune interactions, leading to personalized therapies, drug discovery, and a profound understanding of immune responses. Witness the dawn of transformative healthcare possibilities where data-driven insights redefine how we combat diseases.
Ensure safety and confidence with Aomics’s pharmacovigilance expertise. Our vigilant team monitors, analyzes, and reports adverse events, ensuring patient welfare and regulatory compliance.
Who we are?
Welcome to Aomics GmbH, a German-based data science company that provides comprehensive statistical consulting, programming, and bioinformatics services for healthcare projects, with a particular focus on Immuno-Oncology studies. We possess deep expertise in a wide array of Immuno-Oncology research areas, including clinical statistics, transnational medicine and biomarker research, phase I trials and pharmacokinetic/
Established in 2019, Aomics has recently expanded its global reach by establishing a presence in India, further solidifying our commitment to serving clients worldwide. This expansion reinforces our unwavering dedication to providing unparalleled support and expertise, fostering the advancement of Immuno-Oncology research.
As pioneers in the field, we’re more than just a Clinical solution providers– we’re your strategic partner in scientific progress. Join us on this transformative journey where innovation meets compassion, and together, we shape the future of healthcare.
Dr. Rahul Sharma
Founder & CEO
Dr. Sharma has 15+ years of experience in managing and conducting biological/clinical data analytical projects. Dr. Sharma has published more than 25 research articles in leading peer-reviewed international journals. During his career, Dr. Sharma has played a key role in developing Artificial Intelligence-based computational algorithms. Dr. Sharma trained at the Goethe University, Frankfurt for his PhD in Bioinformatics (DE) and at Uniklinikum Frankfurt (DE) for his post-doctorate research work.
Mr. Stephan Goldenbaum
Chief Sales Officer (CSO)
Mr. Goldenbaum is a seasoned professional with over two decades of invaluable experience in the fields of Life Science, Pharma-Biotech, and Diagnostics. His impressive career has been marked by a relentless commitment to excellence and a strong track record of leadership and business development across diverse global markets, including Europe, the Middle East, and the Asia Pacific region, with companies like QIAGEN, BioMerieux, Eppendorf and during the last 2 years as managing director of SolisBiodyne.
Ms. Sakshi Bharti
Chief Operating Officer (COO)
Ms. Bharti leverages her extensive experience in project management and a background in bioinformatics to drive our startup’s daily operations and strategic growth. With a strong foundation in healthcare data analysis, she ensures our services meet the highest standards. Her role also encompasses forming and nurturing key partnerships, locally and internationally. Currently completing her Ph.D. in Bioinformatics at Goethe University Frankfurt, Ms. Bharti’s innovative thinking and dedication are propelling our startup.
End-to-end drug development solutions
Aomics is dedicated to advancing clinical development with our specialized expertise. We offer comprehensive and cost-effective solutions tailored to meet the distinct needs of universities, research institutes, pharmaceutical companies, biotechnology firms, and contract research organizations (CROs).
“To empower and accelerate clinical development through data-driven insights and innovative solutions. Our mission is to contribute to the discovery and delivery of life-changing therapies, ultimately improving patient outcomes and transforming the future of healthcare.”
“To be a global leader in advancing clinical development through data-driven insights and innovative solutions, driving the delivery of life-changing therapies and transforming healthcare outcomes.”
“As a clinical development company, your primary role is to facilitate and oversee the entire process of bringing new therapies and medical products to market. This involves managing and coordinating various aspects of clinical trials and research studies”
Our key priority
As a clinical data analysis and biostatistics company, our priority is providing accurate insights for clinical development. We analyze complex data, ensuring integrity, statistical rigor, and regulatory compliance. Through collaboration and advanced techniques, we optimize trials, accelerate therapy development, and improve patient care. Our commitment to scientific excellence, ethical conduct, and valuable results empowers clients to make informed decisions and enhance healthcare outcomes.
What We Do
Would you like to start a project with us?
Reach out on the given number or write us an email for further queries regarding project requirements